Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126896371 | 12689637 | 1 | I | 20160818 | 20160826 | 20160826 | EXP | PHHY2016GB115394 | SANDOZ | 99.00 | YR | F | Y | 70.00000 | KG | 20160826 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126896371 | 12689637 | 1 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD | U | U | 0 | 20 | MG | QD | |||||
| 126896371 | 12689637 | 2 | PS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 15 MG, QD | U | U | 76189 | 15 | MG | QD | |||||
| 126896371 | 12689637 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 60 MG, QD 20MG DAILY BUT INCREASED IN DAYS PRIOR TO HOSPITAL ADMISSION TO 60MG DAILY | 0 | 60 | MG | QD | |||||||
| 126896371 | 12689637 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20MG DAILY BUT INCREASED IN DAYS PRIOR TO HOSPITAL ADMISSION TO 60MG DAILY20 MG, QD | 0 | 20 | MG | QD | |||||||
| 126896371 | 12689637 | 5 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 12.5 MG, QD | U | U | 0 | 12.5 | MG | QD | |||||
| 126896371 | 12689637 | 6 | C | CALCICHEW D3 | CALCIUMCHOLECALCIFEROL | 1 | Unknown | U | 0 | ||||||||||
| 126896371 | 12689637 | 7 | C | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | U | 0 | INHALER | |||||||||
| 126896371 | 12689637 | 8 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | U | 0 | ||||||||||
| 126896371 | 12689637 | 9 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126896371 | 12689637 | 1 | Product used for unknown indication |
| 126896371 | 12689637 | 2 | Product used for unknown indication |
| 126896371 | 12689637 | 3 | Product used for unknown indication |
| 126896371 | 12689637 | 5 | Product used for unknown indication |
| 126896371 | 12689637 | 6 | Product used for unknown indication |
| 126896371 | 12689637 | 7 | Product used for unknown indication |
| 126896371 | 12689637 | 8 | Product used for unknown indication |
| 126896371 | 12689637 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126896371 | 12689637 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126896371 | 12689637 | Acute kidney injury | |
| 126896371 | 12689637 | Confusional state | |
| 126896371 | 12689637 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |